Univariate and multivariate Cox regression analyses were then performed to assess whether our model-generated risk scores were independent of other clinical parameters [WHO grade, age, gender, isocitrate dehydrogenase (IDH) mutation status, 1p/19q co-deletion status, and risk score] as prognostic factors for patients with glioma. This evidence concerns the gene IDH3A and glioma.